MMP9 and central nervous system cancer: Propentofylline (PPF), an atypical methylxanthine and glial modulating agent with anti-inflammatory actions, was also shown to be effective in reducing glioma growth by targeting microglia and possibly decreasing their expression of MMP-9 [48].